Fusen Pharmaceutical Co., Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG370981030
HKD
0.78
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Golden Throat Holdings Group Co., Ltd.
Dawnrays Pharmaceutical Holdings Ltd.
TOT BIOPHARM International Co. Ltd.
Shanghai Henlius Biotech, Inc.
Charmacy Pharmaceutical Co., Ltd.
Hua Medicine Ltd.
Immunotech Biopharm Ltd.
Transcenta Holding Ltd.
Abbisko Cayman Ltd.
Zhaoke Ophthalmology Ltd.
Fusen Pharmaceutical Co., Ltd.
Why is Fusen Pharmaceutical Co., Ltd. ?
Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report
Verdict Report
Icon
No Data Found
Is Fusen Pharmaceutical Co., Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Fusen Pharmaceutical Co., Ltd.
-15.22%
-0.09
387.98%
Hang Seng Hong Kong
27.36%
1.03
25.88%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-12.52%
EBIT Growth (5y)
-206.03%
EBIT to Interest (avg)
3.07
Debt to EBITDA (avg)
2.34
Net Debt to Equity (avg)
1.06
Sales to Capital Employed (avg)
0.51
Tax Ratio
1.90%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.65%
ROE (avg)
3.42%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.64
EV to EBIT
-7.26
EV to EBITDA
-14.27
EV to Capital Employed
0.82
EV to Sales
1.89
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-11.36%
ROE (Latest)
-52.05%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Here's what is working for Fusen Pharmaceutical Co., Ltd.
Raw Material Cost
Fallen by 1.93% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at HKD 22.65 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Here's what is not working for Fusen Pharmaceutical Co., Ltd.
Net Profit
At HKD -164.72 MM has Fallen at -370.53%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (HKD MM)

Debt-Equity Ratio
Highest at 105.98 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Operating Cash Flow
Lowest at HKD 44.42 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (HKD MM)

Net Sales
Lowest at HKD 140.71 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (HKD MM)

Net Sales
Fallen at -43.17%
Year on Year (YoY)
MOJO Watch
Near term sales trend is negative

Net Sales (HKD MM)

Interest
Highest at HKD 12.46 MM
in the last five periods and Increased by 32.88% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (HKD MM)

Operating Profit
Lowest at HKD -26.48 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (HKD MM)

Operating Profit Margin
Lowest at -18.82 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
Fallen at -67.92%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (HKD MM)

Net Profit
Lowest at HKD -164.72 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (HKD MM)

EPS
Lowest at HKD -0.22
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (HKD)

Inventory Turnover Ratio
Lowest at 0.92%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio
Lowest at 1.11%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio